Protara Therapeutics, Inc.

TARA

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001359931

SEC filings (opens in a new tab)

No open-market purchases or sales by Protara Therapeutics, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Protara Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of TARA: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	114	3	119	+8
Shares	45.6M	5.21M	46.1M	+5.72M (+14.2%)
Value	$237.4M	$27.2M	$176.0M	−$34.2M (−16.3%)

3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Protara Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to TARA in Q2 2026
Institution	Shares	Value	% of portfolio
Jupiter Topco LLC	4,696,709	$17.9M	0.01%
OrbiMed Advisors LLC	2,220,000	$8.48M	0.16%
Balyasny Asset Management LLC	1,026,691	$3.92M	0.01%
Verdad Advisers, LP	312,249	$1.19M	1.14%
Fisher Asset Management, LLC	99,566	$380.3K	0.00%
Ameriprise Financial Inc	56,267	$214.9K	0.00%
Quadrature Capital Ltd	39,319	$150.2K	0.00%
Public Employees Retirement System of Ohio	29,700	$113.5K	0.00%
Alliancebernstein L.P.	18,040	$94.0K	0.00%
Jain Global LLC	21,000	$80.2K	0.00%
Prelude Capital Management, LLC	19,613	$74.9K	0.01%
EntryPoint Capital, LLC	19,286	$73.7K	0.02%
Squarepoint Ops LLC	18,124	$69.2K	0.00%
Ieq Capital, LLC	17,929	$68.5K	0.00%
Mariner, LLC	11,899	$45.4K	0.00%
Voya Investment Management LLC	11,469	$43.8K	0.00%
D. E. Shaw & Co., Inc.	11,113	$42.5K	0.00%
CI Private Wealth, LLC	10,690	$40.8K	0.00%
SRS Capital Advisors, Inc.	1,671	$6.38K	0.00%
State of Wyoming	960	$3.67K	0.00%
Jones Financial Companies LLLP	402	$1.66K	0.00%
Eastern Bank	71	$271	0.00%
JPL Wealth Management, LLC	4	$16	0.00%
Clearstead Advisors, LLC	3	$12	0.00%
IFP Advisors, Inc	2	$8	0.00%

Sold out (17)

Institutions that held Protara Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of TARA in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
AIGH Capital Management LLC	1,622,733	$8.45M
Patient Square Capital LP	1,030,846	$5.37M
Burkehill Global Management, LP	450,000	$2.34M
ExodusPoint Capital Management, LP	116,305	$605.9K
Fox Run Management, L.L.C.	35,965	$174.4K
Almanack Investment Partners, LLC.	23,782	$123.9K
Engineers Gate Manager LP	21,200	$110.5K
Bailard, Inc.	18,617	$97.0K
Axq Capital, LP	13,002	$67.7K
Cerity Partners LLC	12,748	$66.4K
Toronto Dominion Bank	12,470	$65.0K
Virtu Financial LLC	10,212	$53.0K
Nisa Investment Advisors, LLC	4,800	$25.0K
MAI Capital Management	148	$772
Basecamp Wealth Advisors LLC	82	$427
Root Financial Partners, LLC	5	$26
Wealth Preservation Advisors, LLC	1	$5

Not filed for Q2 2026 yet (3)

Institutions that held Protara Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TARA in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Janus Henderson Group PLC	5,207,011	$27.2M
CWM, LLC	5,846	$30.5K
Sunbelt Securities, Inc.	12	$63